BP000217-CYT-303: Recombinant Human KGF2 (Keratinocyte Growth Factor)
Source: E. coli-derived.
The ED50, calculated by the dose-dependant stimulation of FGF recpetors by BaF3 indicator cells (measured by 3H-thymidine uptake) is < 0.5 ug/ml corresponding to a specific activity of 2 MU/mg.
Purity > 96%, by SDS-PAGE and RP-HPLC.BP000181-CYT-072: Recombinant Mouse Fibroblast Growth Factor Acidic (FGF Acidic) Protein , His Tag
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.BP000181-CYT-075: Recombinant Rat Fibroblast Growth Factor Acidic (FGF Acidic) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent proliferation of mouse BALB/c 3T3 cells, is less than 0.2 ng/ml corresponding to a Specific Activity of 5x106 IU/mg.
Purity: > 98.0% by SDS-PAGE.BP002461-CYT-064: Recombinant Mouse Fibroblast Growth Factor-18 (FGF 18) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF-receptors is < 0.5 ng/ml, corresponding to a specific activity of > 2.0006 units/mg.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP002462-CYT-121: Recombinant Human Fibroblast Growth Factor 13 (FGF13) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.C039P: Abciximab Biosimilar (Research Grade), Anti-human Glycoprotein IIb/IIIa Receptor Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody abciximab biosimilar specifically binds to the human Glycoprotein IIb/IIIa Receptor protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by abciximab.